Page 59 - Advances in Forensic Applications of Mass Spectrometry - Jehuda Yinon

1522_C01.fm Page 46 Tuesday, December 2, 2003 10:05 AM

132. Maurer, H.H. and Kraemer, T., Toxicological detection of selegiline and its
metabolites in urine using fluorescence polarization immunoassay (FPIA)
and gas chromatography-mass spectrometry (GC-MS) and differentiation by
enantioselective GC-MS of the intake of selegiline from abuse of metham-
phetamine or amphetamine, Arch. Toxicol., 66, 675, 1992.
133. Kraemer, T. and Maurer, H.H., Toxicokinetics of amphetamines: metabolism
and toxicokinetic data of designer drugs, of amphetamine, methamphetamine
and their N-alkyl derivatives [review], Ther. Drug Monit., 24, 277, 2002.
134. Musshoff, F., Illegal or legitimate use? Precursor compounds to amphetamine
and methamphetamine [review], Drug Metab. Rev., 32, 15, 2000.
135. Hegadoren, K.M., Baker, G.B., and Bourin, M., 3,4-methylenedioxy ana-
logues of amphetamine: defining the risks to humans, Neurosci. Biobehav.
Rev., 23, 539, 1999.
136. Nichols, D.E., Differences between the mechanism of action of MDMA,
MBDB, and the classic hallucinogens. Identification of a new therapeutic
class: entactogens, J. Psychoactive Drugs, 18, 305, 1986.
137. Jones, A.L. and Simpson, K.J., Review article: mechanisms and management
of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications, Ali-
ment. Pharmacol. Ther., 13, 129, 1999.
138. Walubo, A. and Seger, D., Fatal multi-organ failure after suicidal overdose
with MDMA, “ecstasy”: case report and review of the literature, Hum. Exp.
Toxicol., 18, 119, 1999.
139. Maurer, H.H., Bickeboeller-Friedrich, J., Kraemer, T., and Peters, F.T., Toxi-
cokinetics and analytical toxicology of amphetamine-derived designer drugs
(“Ecstasy”), Toxicol. Lett., 112, 133, 2000.
140. Carvalho, M., Carvalho, F., and Bastos, M.L., Is hyperthermia the triggering
factor for hepatotoxicity induced by 3,4-methylenedioxymethamphetamine
(ecstasy)? An in vitro study using freshly isolated mouse hepatocytes, Arch.
Toxicol., 74, 789, 2001.
141. Garbino, J., Henry, J.A., Mentha, G., and Romand, J.A., Ecstasy ingestion and
fulminant hepatic failure: liver transplantation to be considered as a last
therapeutic option, Vet. Hum. Toxicol., 43, 99, 2001.
142. Ricaurte, G.A., McCann, U.D., Szabo, Z., and Scheffel, U., Toxicodynamics
and long-term toxicity of the recreational drug, 3,4-methylenedioxymetham-
phetamine (MDMA, “Ecstasy”), Toxicol. Lett., 112, 143, 2000.
143. Rochester, J.A. and Kirchner, J.T., Ecstasy (3,4-methylenedioxymethamphet-
amine): history, neurochemistry, and toxicology, J. Am. Board. Fam. Pract.,
12, 137, 1999.
144. Bai, F., Lau, S.S., and Monks, T.J., Glutathione and N-acetylcysteine conju-
gates of alpha-methyldopamine produce serotonergic neurotoxicity: possible
role in methylenedioxyamphetamine-mediated neurotoxicity, Chem. Res.
Toxicol., 12, 1150, 1999.

© 2004 by CRC Press LLC